_256_384.jpg)
News | May 04, 2022
Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
Subscribe To Our Newsletter & Stay Updated
